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Non-tuberculosis mycobacteria (NTM) have emerged as an important pathogen in lung infection. NTM
infection is rarely accompanied by pleural involvement, and empyema necessitatis caused by NTM is very
uncommon. We report a very rare case of Mycobacterium abscessus pulmonary disease with empyema
accompanied by empyema necessitatis. The patient was successfully treated by percutaneous tube
drainage of the empyema and empyema necessitatis with aggressive antibiotics treatment and surgical
resection.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
The prevalence of non-tuberculosis mycobacteria (NTM) infec-
tion is increasingly reported worldwide1e3 and has become an
emerging threat to public health. In South Korea, Mycobacterium
abscessus is the second most common pathogen responsible for
lung disease caused by NTM, following the Mycobacterium avium-
intracellulare complex (MAC).4 Although the most common clinical
manifestation of NTM infection is lung disease, the reported cases
of empyema due to NTM are very rare5e7 and no cases of empyema
necessitatis caused by NTM have been reported so far. Here, we
report a very unusual case of severe M. abscessus infection causing
empyema necessitatis in an immunocompetent patient.2. Case report
A 57 year old man was referred to our hospital for further
evaluation and management of empyema necessitatis. The patient
was an alcoholic and had an 80 pack-year smoking history. Seven
years earlier, he had been treated for pulmonary tuberculosis (TB)
for 3 months at another hospital, but stopped taking pills and failed
to follow up.
Since two years ago, the patient had experienced chronic
coughing. Three months prior to admission, his coughing became
aggravated and he experienced right anterior chest wall swelling
with crepitus. He visited a nearby clinic one month prior to
admission. A chest computed tomography (CT) scan taken at that: þ82 2 3010 6968.
-NC-ND license.clinic showed focal consolidation and cavitation in the right upper
lobe with a ﬁnding suggestive of bronchopleural ﬁstula (Fig. 1).
Because his sputum was positively stained for acid-fast bacilli
(AFB), he was started on anti-TB medication. Although he had kept
taking pills regularly, his right anterior chest wall swelling had
become aggravated in size and turned into abscess. Then he was
referred to our hospital for further management.
On physical examination, the patient was alert and in no
distress. His height was 160 cm and body weight was 44 kg. His
body temperature was 36.9 C, blood pressure was 100/60 mmHg,
pulse was 70 beats per minute with a regular rhythm, and respi-
ratory rate was 20 breaths per minute. Inspiratory crackles and
decreased breathing sound were heard in the right upper anterior
chest ﬁeld. Complete blood count revealed WBC of 17,000/mm3
(neutrophils 85%), hemoglobin 12.3 g/dL and platelets 412 k/mm3.
C-reactive protein concentration was 8.7 mg/dL. Routine chemical
laboratory data were all within normal range. The patient was
negative for antibody to human immunodeﬁciency virus.
Sputum AFB smear and culture were repeated and anti-TB
medication was continued. Compared with previous chest CT
scan taken one month earlier, his chest CT scan showed
increased amount of pleural effusion with newly developed
empyema necessitatis in right anterior chest wall (Fig. 2A). To
drain his pleural ﬂuid, one chest tube was inserted into the
pleural space and another tube was inserted into the empyema
necessitatis. The drained pleural ﬂuid was grossly pus and the
ﬂuid contained 550,000 WBC/mm3 (with a differential of 99%
neutrophil) with a pH 7.0. The pleural ﬂuid had a protein
concentration of 5.2 g/dL, a glucose concentration of 5 mg/dL,
a lactic acid dehydrogenase concentration of 1233 U/L and it was
stained positively for AFB.
Fig. 1. Initial chest CT scan showed that cavitation with focal consolidation, pleural
effusion and pleural wall thickness in right upper lobe. There were diffuse inﬁltration
and air collection at the soft tissue of right anterior chest wall, which suggest the
presence of bronchopleural ﬁstula.
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in the sputum and pleural ﬂuid samples were negative using
a commercial DNA probe. The PCR-restriction fragment length
polymorphism analysis targeting rpoB gene identiﬁed M. abscessus
from the patient’s sputum and pleural ﬂuid specimens.8 The AFB
culture of sputum and pleural ﬂuid eventually yieldedM. abscessus
growth.
Based on these clinical ﬁndings and laboratory data, the patient
was diagnosed as having pulmonary and pleural infection with
empyema necessitatis caused by M. abscessus. Anti-TB medication
was discontinued and antibiotic treatment for M. abscessus was
initiated (oral clarithromycin 1000 mg/day, intravenous cefoxitin
10 g/day and intravenous amikacin 750 mg/day). Even six weeksFig. 2. A. Chest CT scan one month later showed that progression of lung inﬂammation a
developed large bulging contour with irregular air density at right anterior chest wallindica
initiation showed that decreased size of empyema, disappearance of bronchopleural ﬁstula
Chest tube was inserted into the right pleural space.after initiation of antibiotics, however, pleural ﬂuid was still posi-
tive for AFB. Ciproﬂoxacin 800 mg/day was added and then the AFB
stain became negative.
A chest radiography and CT scan taken about three months after
treatment initiation against M. abscessus showed improvement of
empyema necessitatis, pleural and lung parenchymal infection
(Fig. 2B). After removal of the drainage tube, round-shaped skin
defect with soft tissue exposure occurred (Fig. 3A), and he under-
went skin graft implantation (Fig. 3B). Six months after initiation of
the treatment, he received right upper lobectomy of lung, which
showed chronic granulomatous inﬂammation with multifocal
microabscesses microscopically (Fig. 4). Treatment was completed
after a total of one and half years of antibiotic treatment.3. Discussion
We have described here a very rare case of empyema neces-
sitatis caused by M. abscessus, in which the lung parenchyma as
well as the pleura and overlying soft tissue were all involved.
Although the clinical and radiological characteristics of NTM
infection resemble those of TB, NTM infection is rarely accompa-
nied by pleural involvement.7 There have been a few case reports of
pleural effusion caused by NTM such as MAC,9e12 Mycobacterium
kansasii,13,14 Mycobacterium scrofulaceum.15 Only a few cases of
chronic empyema due to MAC were also reported.5e7 In the case of
M. abscessus, only one case of M. abscessus empyema in a lung
transplant recipient was reported.16 None of these cases, however,
reported the development of empyema necessitatis in the patients
with pulmonary and pleural infection caused by NTM. To our
knowledge, this is the ﬁrst case report of empyema necessitatis
caused by NTM, speciﬁcally M. abscessus.
American Thoracic Society guidelines described M. abscessus
disease as a chronic incurable infection for most patients,17 which
reﬂect the difﬁculty of treatment against this organism. It was also
stated that, however, curative therapy is more likely to be obtained
with limited disease and a combination of surgical resection of
involved lung and chemotherapy.17 Because pulmonary-pleural
infection was limited in our patients, he had been treated with
multidrug chemotherapy including oral and intravenous antibiotics
combined with tubal drainage and surgical resection, which lead tond bronchopleural ﬁstula with increased amount of pleural effusion. Note the newly
tes the empyema necessitatis formation. B. Chest CT scan three month after treatment
in right upper lobe and improved empyema necessitatis at right anterior chest wall.
Fig. 3. A. The anterior chest wall abscess with a skin defect after removal of the drainage catheter. B. After skin graft implantation.
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M. abscessus in a lung transplant recipient has been reported,16 the
treatment outcome of M. abscessus empyema is unclear, although
this recipient died because of multiorgan failure. Our case suggests
that, however, even more severe form of M. abscessus lung disease
extending chest wall, can be cured with aggressive medical therapy
and operation if the infection is conﬁned to resectable area.
Several studies have reported the treatment outcome of
M. abscessus pulmonary disease. In South Korea, Lyu et al. reported
80.5% treatment success rate in 41 patients,18 and Jeon et al. re-
ported 58% treatment success rate in 65 patients,19 of which
treatment success rates tend to be higher than other countries.20,21
Recently, it was revealed that M. abscessus comprises three closely
related species: M. abscessus, Mycobacterium massiliense and
Mycobacterium bolletii.4 In South Korea, M. abscessus and M. mas-
siliense are isolated in almost equal numbers among M. abscessus
complex infections, whereas M. bolletii is rare.4 According to the
report, the microbiologic treatment response rate was higher in
patients with M. massiliense lung disease than in those with M.
abscessus lung disease.4 However, in our study, the clinical isolate of
M. abscessus could not be further identiﬁed to this subspecies level.Fig. 4. Pathologic specimen of right upper lobe showed that the external surface of the
lung was brownish red, ﬁbrous and irregular. There were chronic granulomatous
inﬂammation with bronchiectasis, multifocal microabscesses and intrapulmonary/
pleural ﬁbrosis microscopically.The pathway of NTM infection to empyema is uncertain, but
there are two theories about the process.5 The ﬁrst theory is the
development of the empyema from the lung infection. The second
theory entails the development of the empyema after a minor
trauma. A Chest CT scan in our case showed that the possible
presence of bronchopleural ﬁstula, which suggests that empyema
in the present case resulted from pulmonary parenchymal infection
through a bronchopleural ﬁstula. Empyema necessitatis is generally
thought to be complication of empyema in which the pleural
infection spreads outside of the pleural space to involve the soft
tissue of the chest wall. Bronchopleural ﬁstula associated with
tuberculosis usually follows a surgical procedure but can also occur
spontaneously.22,23 Park et al. suggested that development of
spontaneous bronchopleural ﬁstula due to pulmonary MAC infec-
tion could be possible.7 Our case also support this suggestion that
spontaneous bronchopleural ﬁstula can happen in pulmonary NTM
infection, including M. abscessus.
In summary, our case suggests that NTM such as M. abscessus is
capable of causing empyema and empyema necessitatis as well as
lung parenchymal infection. Physicians should be aware of the
possibility of pulmonary infection and empyema associated with
empyema necessitatis caused by M. abscessus even in immuno-
competent patients.Conﬂict of interest statement
No author has a conﬂict of interest to disclose.References
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